Bausch Health Companies Inc. (BHC) P/B ratio
The P/B ratio of Bausch Health Companies Inc. (BHC) was 13.8× at the end of fiscal 2020 (December 31, 2020). That is 39.3% higher than the 9.9× of fiscal 2019. Figures as of 18 Nov 2026, 05:53 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- P/B ratio, fiscal 2020
- 13.8×
- Change on fiscal 2019
- +39.3%
- Highest on record
- 13.8×fiscal 2020
- Lowest on record
- 1.1×fiscal 2010
- Fiscal years on record
- 132008–2020
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Bausch Health Companies Inc. P/B ratio, in more detail
Across the 13 fiscal year-ends on record (2008–2020), the highest was 13.8× in fiscal 2020 and the lowest 1.1× in fiscal 2010.
P/B ratio at each fiscal year-end
Bausch Health Companies Inc. P/B ratio, year by year
| Fiscal year | P/B ratio | Change | Year ended | Share price at year-end | Book value per share |
|---|---|---|---|---|---|
| 2025 | — | — | $6.95 | -$1.48 | |
| 2024 | — | — | $8.06 | -$3.61 | |
| 2023 | — | — | $8.02 | -$2.80 | |
| 2022 | — | — | $6.28 | -$1.91 | |
| 2021 | — | — | $27.61 | -$0.30 | |
| 2020 | 13.8× | 39.3% up | $20.80 | $1.51 | |
| 2019 | 9.9× | 317.4% up | $29.92 | $3.02 | |
| 2018 | 2.4× | 90.0% up | $18.47 | $7.78 | |
| 2017 | 1.2× | 21.9% down | $20.78 | $16.63 | |
| 2016 | 1.6× | 72.9% down | $14.52 | $9.08 | |
| 2015 | 5.9× | 36.3% down | $101.65 | $17.25 | |
| 2014 | 9.3× | 25.7% up | $143.11 | $15.46 | |
| 2013 | 7.4× | 49.9% up | $117.40 | $15.95 | |
| 2012 | 4.9× | 26.7% up | $59.77 | $12.17 | |
| 2011 | 3.9× | 243.5% up | $46.69 | $12.05 | |
| 2010 | 1.1× | 31.0% down | $28.29 | $25.08 | |
| 2009 | 1.6× | 30.1% up | $13.96 | $8.54 | |
| 2008 | 1.3× | — | $9.45 | $7.52 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.
How to read it
It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.
Bausch Health Companies Inc., figure by figure
- Bausch Health Companies Inc. market cap
- Bausch Health Companies Inc. revenue
- Bausch Health Companies Inc. earnings
- Bausch Health Companies Inc. earnings per share (EPS)
- Bausch Health Companies Inc. P/E ratio
- Bausch Health Companies Inc. P/S ratio
- Bausch Health Companies Inc. free cash flow
- Bausch Health Companies Inc. operating margin
- Bausch Health Companies Inc. dividend
- Bausch Health Companies Inc. shares outstanding
- Bausch Health Companies Inc. total debt
- Bausch Health Companies Inc. cash on hand
- Bausch Health Companies Inc. total assets
- Bausch Health Companies Inc. return on equity (ROE)
- Bausch Health Companies Inc. return on invested capital (ROIC)
Bausch Health Companies Inc. (BHC) overview: price, valuation and scorecard
Bausch Health Companies Inc. P/B ratio: questions and answers
What is Bausch Health Companies Inc.'s P/B ratio?
The P/B ratio of Bausch Health Companies Inc. (BHC) was 13.8× at the end of fiscal 2020 (December 31, 2020). That is 39.3% higher than the 9.9× of fiscal 2019.
What are the highest and lowest P/B ratio figures on record for Bausch Health Companies Inc.?
Across the 13 fiscal year-ends on record (2008–2020), the highest was 13.8× in fiscal 2020 and the lowest 1.1× in fiscal 2010.
How is Bausch Health Companies Inc.'s P/B ratio calculated?
The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/B ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Piotroski F-score: the nine tests and what they show
The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Bausch Health Companies Inc. (BHC) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/BHC/pb-ratio
Underlying data: the company's filings with the SEC and Yahoo Finance.